Long-term follow-up of women with genital lichen sclerosus

TY - JOUR

T1 - Long-term follow-up of women with genital lichen sclerosus

AU - Green, C.

AU - Guest, J.

AU - Ngu, W.

PY - 2013

Y1 - 2013

N2 - Genital lichen sclerosus (LS) is usually managed with potent topical corticosteroids. There is a small (<5%) increased risk of skin cancer and long-term follow-up is recommended. We audited patients discharged to the care of their general practitioner (GP) from our regional vulval clinic. Only 29% had seen their GP in the last 12 months; 53% self-examined; 48% were unaware of the need to report abnormalities immediately; 24.4% were unaware of the recommended duration of use of their 30 g tube of steroid and only 66.7% were aware of the risk of skin cancer. Further education of both LS patients and their family practitioners is required.

AB - Genital lichen sclerosus (LS) is usually managed with potent topical corticosteroids. There is a small (<5%) increased risk of skin cancer and long-term follow-up is recommended. We audited patients discharged to the care of their general practitioner (GP) from our regional vulval clinic. Only 29% had seen their GP in the last 12 months; 53% self-examined; 48% were unaware of the need to report abnormalities immediately; 24.4% were unaware of the recommended duration of use of their 30 g tube of steroid and only 66.7% were aware of the risk of skin cancer. Further education of both LS patients and their family practitioners is required.

KW - lichen

KW - genital

KW - sclerosus

UR - https://www.scopus.com/pages/publications/84879427420

U2 - 10.1177/1754045312472861

DO - 10.1177/1754045312472861

M3 - Article

C2 - 23417579

AN - SCOPUS:84879427420

SN - 2053-3691

VL - 19

SP - 28

EP - 29

JO - Post Reproductive Health

JF - Post Reproductive Health

IS - 1

ER -